She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research
FotoshopTofs / Pixabay

She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research

According to a story from 9news.com.au, the first sign that Jemima Leydon had ovarian cancer was a stomachache. Her mother Megan assumed that it was just a stomach bug that…

Continue Reading She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research
Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease
jniittymaa0 / Pixabay

Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease

A new drug designed to treat MAC lung disease as part of a combination antibacterial drug regimen in adults with limited treatment options has been granted Accelerated Approval by the…

Continue Reading Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease
After Reviewing Publications About MPS III, Researchers Say More Studies Need to be Carried Out
jarmoluk / Pixabay

After Reviewing Publications About MPS III, Researchers Say More Studies Need to be Carried Out

Researchers have carried out a literature review to investigate MPS III. After reviewing forty-six papers, they concluded that more research needs to be carried out. You can find the original study…

Continue Reading After Reviewing Publications About MPS III, Researchers Say More Studies Need to be Carried Out
The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)
qimono / Pixabay

The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)

The United States Food and Drug Administration has approved Copiktra™ (duvelisib). The drug is now approved as a treatment for adult patients diagnosed with refractory or relapsed chronic lymphocytic leukaemia…

Continue Reading The FDA has Approved a New Cancer Drug Called Copiktra™ (duvelisib)

A Study of a Potential Drug for Primary Biliary Cholangitis has Exceeded its Patient Enrolment Target

The company Genkyotex has announced that they have finished enrolling participants for a Phase 2 clinical trial of the investigational drug GKT831 in patients who have primary biliary cholangitis. The…

Continue Reading A Study of a Potential Drug for Primary Biliary Cholangitis has Exceeded its Patient Enrolment Target